Italy · Delayed Price · Currency is EUR PiùMedical Statistics
Total Valuation
PiùMedical has a market cap or net worth of EUR 38.80 million. The enterprise value is 34.53 million.
| Market Cap | 38.80M |
| Enterprise Value | 34.53M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
PiùMedical has 7.53 million shares outstanding.
| Current Share Class | 7.18M |
| Shares Outstanding | 7.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 2.52% |
| Float | 3.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 27.11 |
| PS Ratio | 5.84 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 3.86 |
| P/FCF Ratio | 20.95 |
| P/OCF Ratio | 15.68 |
| PEG Ratio | 0.51 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 102.48, with an EV/FCF ratio of 18.65.
| EV / Earnings | n/a |
| EV / Sales | 5.20 |
| EV / EBITDA | 102.48 |
| EV / EBIT | 251.90 |
| EV / FCF | 18.65 |
Financial Position
The company has a current ratio of 3.32, with a Debt / Equity ratio of 0.37.
| Current Ratio | 3.32 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 40.80 |
| Debt / FCF | 7.42 |
| Interest Coverage | 0.69 |
Financial Efficiency
Return on equity (ROE) is -0.13% and return on invested capital (ROIC) is 0.42%.
| Return on Equity (ROE) | -0.13% |
| Return on Assets (ROA) | 0.18% |
| Return on Invested Capital (ROIC) | 0.42% |
| Return on Capital Employed (ROCE) | 0.27% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 93,589 |
| Profits Per Employee | -617 |
| Employee Count | 71 |
| Asset Turnover | 0.14 |
| Inventory Turnover | 2.36 |
Taxes
| Income Tax | -21,098 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 6.00 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 28.87 |
| Average Volume (20 Days) | 7,088 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PiùMedical had revenue of EUR 6.64 million and -43,804 in losses. Loss per share was -0.01.
| Revenue | 6.64M |
| Gross Profit | 1.53M |
| Operating Income | 137,059 |
| Pretax Income | -61,545 |
| Net Income | -43,804 |
| EBITDA | 173,338 |
| EBIT | 137,059 |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 18.68 million in cash and 13.74 million in debt, with a net cash position of 4.94 million or 0.66 per share.
| Cash & Cash Equivalents | 18.68M |
| Total Debt | 13.74M |
| Net Cash | 4.94M |
| Net Cash Per Share | 0.66 |
| Equity (Book Value) | 37.29M |
| Book Value Per Share | 4.86 |
| Working Capital | 15.67M |
Cash Flow
In the last 12 months, operating cash flow was 2.48 million and capital expenditures -623,466, giving a free cash flow of 1.85 million.
| Operating Cash Flow | 2.48M |
| Capital Expenditures | -623,466 |
| Depreciation & Amortization | 36,279 |
| Net Borrowing | 5.69M |
| Free Cash Flow | 1.85M |
| FCF Per Share | 0.25 |
Margins
Gross margin is 23.08%, with operating and profit margins of 2.06% and -0.66%.
| Gross Margin | 23.08% |
| Operating Margin | 2.06% |
| Pretax Margin | -0.93% |
| Profit Margin | -0.66% |
| EBITDA Margin | 2.61% |
| EBIT Margin | 2.06% |
| FCF Margin | 27.87% |
Dividends & Yields
PiùMedical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.11% |
| FCF Yield | 4.77% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PiùMedical has an Altman Z-Score of 1.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 3 |